Cita APA

Kushner, B. H., LaQuaglia, M. P., Modak, S., Wolden, S. L., Basu, E. M., Roberts, S. S., . . . Cheung, N. V. (2017). MYCN-amplified stage 2/3 neuroblastoma: Excellent survival in the era of anti-G(D2) immunotherapy. Oncotarget.

Citación estilo Chicago

Kushner, Brian H., et al. "MYCN-amplified Stage 2/3 Neuroblastoma: Excellent Survival in the Era of Anti-G(D2) Immunotherapy." Oncotarget 2017.

Cita MLA

Kushner, Brian H., et al. "MYCN-amplified Stage 2/3 Neuroblastoma: Excellent Survival in the Era of Anti-G(D2) Immunotherapy." Oncotarget 2017.